Elon Musk's Neuralink says it has FDA approval for first human clinical study
- Elon Musk's brain-implant company, Neuralink, has received FDA approval to begin its first-in-human clinical study after initially facing rejection due to safety concerns.
- The implant aims to treat conditions such as paralysis and blindness through direct brain-computer interfacing.
- The approval represents an important first step for the company's technology and comes as U.S. lawmakers raise concerns over animal testing and experimental procedures at Neuralink.
Published 14 days ago · S F, United States
Times of India
Elon Musk's Neuralink says cleared for human test of brain implants
Neuralink said clearance from the US Food and Drug Administration (FDA) for its first in-human clinical study is "an important first step" for its technology, which is intended to let brains interface directly with computers.
14 days ago·Mumbai, IndiaRead Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Time & Location
Sources are mostly out of (0)